Tools & Techniques

Explore the trends, tools, and challenges shaping how scientists screen drug candidates to advance therapeutic discovery.

LGC Standards reveals new 13C-labelled PFAS mixtures and single solutions to support laboratories using EPA Method 1633.

From vascularized organoids to Parkinson's disease in a dish, scientists are pushing the boundaries of 3D cell research.

How can researchers translate spatial transcriptomic discoveries into clinically actionable biomarker panels using multiplex immunofluorescence?

From multiomic diagnostics to quantum computing, leading experts share the untapped opportunities that could reshape the future of therapeutics.

QIAGEN Digital Insights bioinformatics bring over 25 years of expertise in expert-curated content, AI-powered proprietary algorithms and user-friendly tools to simplify NGS data analysis

A new class of small-molecule drugs could represent a therapeutic modality aimed at eliminating disease-causing proteins before they spread in the body.

The growing Alliance continues to build the most comprehensive clinical genomic dataset to advance human health.

Researchers can now train AI models on over 5 million protein-ligand structures to predict drug potency faster and more accurately than ever.

The drugmaker expands access to AI-driven discovery, but also positions its technology to become a standard across the sector.

Specialized AI agents automate research workflows and accelerate drug discovery and development with transparent, evidence-backed insights.